https://www.iongenomics.bio/p/tempus-predicta-biosciences-to-offerIon Genomicsen2026-04-16T17:01:56+00:00Tempus, Predicta Biosciences to Offer Co-Branded WGS-Based Assay for Blood Cancershttps://www.iongenomics.bio/p/cepheid-oxford-nanopore-proceed-withIon Genomicsen2026-04-16T16:50:54+00:00Cepheid, Oxford Nanopore Proceed With Infectious Disease Research Partnershiphttps://www.iongenomics.bio/p/pacbio-and-covaris-develop-workflowIon Genomicsen2026-04-16T16:36:10+00:00PacBio and Covaris Develop Workflow for Sequencing FFPE Tumor Sampleshttps://www.iongenomics.bio/p/roches-foundation-medicine-to-addIon Genomicsen2026-04-16T16:24:17+00:00Roche’s Foundation Medicine to Add Saga Diagnostics' MRD Platform Following $595M Acquisition